Report Detail
Global Exosome Therapy Market Insights, Forecast to 2028
- RnM4426733 |
- 26 April, 2022 |
- Global |
- 108 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Market Analysis and Insights: Global Exosome Therapy Market
Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.
The global Exosome Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Direct Treatment accounting for % of the Exosome Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Exosome Therapy market size is valued at US$ million in 2021, while the North America and Europe Exosome Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Exosome Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exosome Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exosome Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exosome Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exosome Therapy market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Exosome Therapy market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Exosome Therapy Breakdown Data by Type
Direct Treatment
Drug Delivery Vehicle
Exosome Therapy Breakdown Data by Application
Hospital
Clinic
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
United Therapeutics Corporation
Codiak BioSciences
EngEx™
Esperite Group
ArunA Biomedical
Evox Therapeutics
NeurExo Sciences
Tavec Pharmaceuticals
AEGLE Therapeutics
Avalon GloboCare
AlligatorBioscience
Capricor Therapeutics
Stem Cell Medicine
CellTex Therapeutics
Frequently Asked Questions
What factors will challenge the Exosome Therapy market growth?
Which end-use segment will expand at the fastest CAGR in the Exosome Therapy market?
Which are the emerging players in the Exosome Therapy market?
How concentrated is the Exosome Therapy market?
Which factors are positively contributing to the Exosome Therapy market growth?
Which are the novel product innovations in the Exosome Therapy market?
Which product segment will emerge as the most lucrative in the Exosome Therapy market?
Which factors are increasing the competition in the Exosome Therapy market?
Which are the strategic measures taken by the Exosome Therapy industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Exosome Therapy market in the coming years?
Table of Contents
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Exosome Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Direct Treatment
- 1.2.3 Drug Delivery Vehicle
- 1.3 Market by Application
- 1.3.1 Global Exosome Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Research Institutions
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Exosome Therapy Market Perspective (2017-2028)
- 2.2 Exosome Therapy Growth Trends by Region
- 2.2.1 Exosome Therapy Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Exosome Therapy Historic Market Size by Region (2017-2022)
- 2.2.3 Exosome Therapy Forecasted Market Size by Region (2023-2028)
- 2.3 Exosome Therapy Market Dynamics
- 2.3.1 Exosome Therapy Industry Trends
- 2.3.2 Exosome Therapy Market Drivers
- 2.3.3 Exosome Therapy Market Challenges
- 2.3.4 Exosome Therapy Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Exosome Therapy Players by Revenue
- 3.1.1 Global Top Exosome Therapy Players by Revenue (2017-2022)
- 3.1.2 Global Exosome Therapy Revenue Market Share by Players (2017-2022)
- 3.2 Global Exosome Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Exosome Therapy Revenue
- 3.4 Global Exosome Therapy Market Concentration Ratio
- 3.4.1 Global Exosome Therapy Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapy Revenue in 2021
- 3.5 Exosome Therapy Key Players Head office and Area Served
- 3.6 Key Players Exosome Therapy Product Solution and Service
- 3.7 Date of Enter into Exosome Therapy Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapy Breakdown Data by Type
- 4.1 Global Exosome Therapy Historic Market Size by Type (2017-2022)
- 4.2 Global Exosome Therapy Forecasted Market Size by Type (2023-2028)
5 Exosome Therapy Breakdown Data by Application
- 5.1 Global Exosome Therapy Historic Market Size by Application (2017-2022)
- 5.2 Global Exosome Therapy Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Exosome Therapy Market Size (2017-2028)
- 6.2 North America Exosome Therapy Market Size by Type
- 6.2.1 North America Exosome Therapy Market Size by Type (2017-2022)
- 6.2.2 North America Exosome Therapy Market Size by Type (2023-2028)
- 6.2.3 North America Exosome Therapy Market Share by Type (2017-2028)
- 6.3 North America Exosome Therapy Market Size by Application
- 6.3.1 North America Exosome Therapy Market Size by Application (2017-2022)
- 6.3.2 North America Exosome Therapy Market Size by Application (2023-2028)
- 6.3.3 North America Exosome Therapy Market Share by Application (2017-2028)
- 6.4 North America Exosome Therapy Market Size by Country
- 6.4.1 North America Exosome Therapy Market Size by Country (2017-2022)
- 6.4.2 North America Exosome Therapy Market Size by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Exosome Therapy Market Size (2017-2028)
- 7.2 Europe Exosome Therapy Market Size by Type
- 7.2.1 Europe Exosome Therapy Market Size by Type (2017-2022)
- 7.2.2 Europe Exosome Therapy Market Size by Type (2023-2028)
- 7.2.3 Europe Exosome Therapy Market Share by Type (2017-2028)
- 7.3 Europe Exosome Therapy Market Size by Application
- 7.3.1 Europe Exosome Therapy Market Size by Application (2017-2022)
- 7.3.2 Europe Exosome Therapy Market Size by Application (2023-2028)
- 7.3.3 Europe Exosome Therapy Market Share by Application (2017-2028)
- 7.4 Europe Exosome Therapy Market Size by Country
- 7.4.1 Europe Exosome Therapy Market Size by Country (2017-2022)
- 7.4.2 Europe Exosome Therapy Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Exosome Therapy Market Size (2017-2028)
- 8.2 Asia-Pacific Exosome Therapy Market Size by Type
- 8.2.1 Asia-Pacific Exosome Therapy Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Exosome Therapy Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Exosome Therapy Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Exosome Therapy Market Size by Application
- 8.3.1 Asia-Pacific Exosome Therapy Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Exosome Therapy Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Exosome Therapy Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Exosome Therapy Market Size by Region
- 8.4.1 Asia-Pacific Exosome Therapy Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Exosome Therapy Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Exosome Therapy Market Size (2017-2028)
- 9.2 Latin America Exosome Therapy Market Size by Type
- 9.2.1 Latin America Exosome Therapy Market Size by Type (2017-2022)
- 9.2.2 Latin America Exosome Therapy Market Size by Type (2023-2028)
- 9.2.3 Latin America Exosome Therapy Market Share by Type (2017-2028)
- 9.3 Latin America Exosome Therapy Market Size by Application
- 9.3.1 Latin America Exosome Therapy Market Size by Application (2017-2022)
- 9.3.2 Latin America Exosome Therapy Market Size by Application (2023-2028)
- 9.3.3 Latin America Exosome Therapy Market Share by Application (2017-2028)
- 9.4 Latin America Exosome Therapy Market Size by Country
- 9.4.1 Latin America Exosome Therapy Market Size by Country (2017-2022)
- 9.4.2 Latin America Exosome Therapy Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Exosome Therapy Market Size (2017-2028)
- 10.2 Middle East & Africa Exosome Therapy Market Size by Type
- 10.2.1 Middle East & Africa Exosome Therapy Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Exosome Therapy Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Exosome Therapy Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Exosome Therapy Market Size by Application
- 10.3.1 Middle East & Africa Exosome Therapy Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Exosome Therapy Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Exosome Therapy Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Exosome Therapy Market Size by Country
- 10.4.1 Middle East & Africa Exosome Therapy Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Exosome Therapy Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 United Therapeutics Corporation
- 11.1.1 United Therapeutics Corporation Company Details
- 11.1.2 United Therapeutics Corporation Business Overview
- 11.1.3 United Therapeutics Corporation Exosome Therapy Introduction
- 11.1.4 United Therapeutics Corporation Revenue in Exosome Therapy Business (2017-2022)
- 11.1.5 United Therapeutics Corporation Recent Developments
- 11.2 Codiak BioSciences
- 11.2.1 Codiak BioSciences Company Details
- 11.2.2 Codiak BioSciences Business Overview
- 11.2.3 Codiak BioSciences Exosome Therapy Introduction
- 11.2.4 Codiak BioSciences Revenue in Exosome Therapy Business (2017-2022)
- 11.2.5 Codiak BioSciences Recent Developments
- 11.3 EngEx™
- 11.3.1 EngEx™ Company Details
- 11.3.2 EngEx™ Business Overview
- 11.3.3 EngEx™ Exosome Therapy Introduction
- 11.3.4 EngEx™ Revenue in Exosome Therapy Business (2017-2022)
- 11.3.5 EngEx™ Recent Developments
- 11.4 Esperite Group
- 11.4.1 Esperite Group Company Details
- 11.4.2 Esperite Group Business Overview
- 11.4.3 Esperite Group Exosome Therapy Introduction
- 11.4.4 Esperite Group Revenue in Exosome Therapy Business (2017-2022)
- 11.4.5 Esperite Group Recent Developments
- 11.5 ArunA Biomedical
- 11.5.1 ArunA Biomedical Company Details
- 11.5.2 ArunA Biomedical Business Overview
- 11.5.3 ArunA Biomedical Exosome Therapy Introduction
- 11.5.4 ArunA Biomedical Revenue in Exosome Therapy Business (2017-2022)
- 11.5.5 ArunA Biomedical Recent Developments
- 11.6 Evox Therapeutics
- 11.6.1 Evox Therapeutics Company Details
- 11.6.2 Evox Therapeutics Business Overview
- 11.6.3 Evox Therapeutics Exosome Therapy Introduction
- 11.6.4 Evox Therapeutics Revenue in Exosome Therapy Business (2017-2022)
- 11.6.5 Evox Therapeutics Recent Developments
- 11.7 NeurExo Sciences
- 11.7.1 NeurExo Sciences Company Details
- 11.7.2 NeurExo Sciences Business Overview
- 11.7.3 NeurExo Sciences Exosome Therapy Introduction
- 11.7.4 NeurExo Sciences Revenue in Exosome Therapy Business (2017-2022)
- 11.7.5 NeurExo Sciences Recent Developments
- 11.8 Tavec Pharmaceuticals
- 11.8.1 Tavec Pharmaceuticals Company Details
- 11.8.2 Tavec Pharmaceuticals Business Overview
- 11.8.3 Tavec Pharmaceuticals Exosome Therapy Introduction
- 11.8.4 Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2017-2022)
- 11.8.5 Tavec Pharmaceuticals Recent Developments
- 11.9 AEGLE Therapeutics
- 11.9.1 AEGLE Therapeutics Company Details
- 11.9.2 AEGLE Therapeutics Business Overview
- 11.9.3 AEGLE Therapeutics Exosome Therapy Introduction
- 11.9.4 AEGLE Therapeutics Revenue in Exosome Therapy Business (2017-2022)
- 11.9.5 AEGLE Therapeutics Recent Developments
- 11.10 Avalon GloboCare
- 11.10.1 Avalon GloboCare Company Details
- 11.10.2 Avalon GloboCare Business Overview
- 11.10.3 Avalon GloboCare Exosome Therapy Introduction
- 11.10.4 Avalon GloboCare Revenue in Exosome Therapy Business (2017-2022)
- 11.10.5 Avalon GloboCare Recent Developments
- 11.11 AlligatorBioscience
- 11.11.1 AlligatorBioscience Company Details
- 11.11.2 AlligatorBioscience Business Overview
- 11.11.3 AlligatorBioscience Exosome Therapy Introduction
- 11.11.4 AlligatorBioscience Revenue in Exosome Therapy Business (2017-2022)
- 11.11.5 AlligatorBioscience Recent Developments
- 11.12 Capricor Therapeutics
- 11.12.1 Capricor Therapeutics Company Details
- 11.12.2 Capricor Therapeutics Business Overview
- 11.12.3 Capricor Therapeutics Exosome Therapy Introduction
- 11.12.4 Capricor Therapeutics Revenue in Exosome Therapy Business (2017-2022)
- 11.12.5 Capricor Therapeutics Recent Developments
- 11.13 Stem Cell Medicine
- 11.13.1 Stem Cell Medicine Company Details
- 11.13.2 Stem Cell Medicine Business Overview
- 11.13.3 Stem Cell Medicine Exosome Therapy Introduction
- 11.13.4 Stem Cell Medicine Revenue in Exosome Therapy Business (2017-2022)
- 11.13.5 Stem Cell Medicine Recent Developments
- 11.14 CellTex Therapeutics
- 11.14.1 CellTex Therapeutics Company Details
- 11.14.2 CellTex Therapeutics Business Overview
- 11.14.3 CellTex Therapeutics Exosome Therapy Introduction
- 11.14.4 CellTex Therapeutics Revenue in Exosome Therapy Business (2017-2022)
- 11.14.5 CellTex Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Exosome Therapy. Industry analysis & Market Report on Exosome Therapy is a syndicated market report, published as Global Exosome Therapy Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Exosome Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
